Cordasco Financial Network’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $101K | Buy |
1,315
+8
| +0.6% | +$609 | 0.07% | 131 |
|
|
2022
Q1 | $95K | Buy |
1,307
+10
| +0.8% | +$671 | 0.06% | 139 |
|
|
2021
Q4 | $81K | Buy |
1,297
+9
| +0.7% | +$528 | 0.05% | 148 |
|
|
2021
Q3 | $76K | Sell |
1,288
-206
| -14% | -$13.6K | 0.05% | 147 |
|
|
2021
Q2 | $100K | Buy |
1,494
+9
| +0.6% | +$587 | 0.07% | 130 |
|
|
2021
Q1 | $94K | Sell |
1,485
-42
| -3% | -$2.61K | 0.07% | 123 |
|
|
2020
Q4 | $95K | Buy |
1,527
+208
| +16% | +$12.8K | 0.08% | 116 |
|
|
2020
Q3 | $80K | Sell |
1,319
-193
| -13% | -$11.6K | 0.07% | 126 |
|
|
2020
Q2 | $89K | Buy |
1,512
+185
| +14% | +$11.1K | 0.08% | 117 |
|
|
2020
Q1 | $74K | Buy |
1,327
+132
| +11% | +$8.07K | 0.08% | 107 |
|
|
2019
Q4 | $77K | Buy |
1,195
+7
| +0.6% | +$401 | 0.07% | 111 |
|
|
2019
Q3 | $60K | Buy |
1,188
+10
| +0.8% | +$470 | 0.06% | 115 |
|
|
2019
Q2 | $53K | Buy |
1,178
+9
| +0.8% | +$419 | 0.05% | 121 |
|
|
2019
Q1 | $56K | Buy |
1,169
+1,029
| +735% | +$51.3K | 0.06% | 115 |
|
|
2018
Q4 | $7K | Hold |
140
| – | – | 0.01% | 273 |
|
|
2018
Q3 | $9K | Sell |
140
-203
| -59% | -$12K | 0.01% | 242 |
|
|
2018
Q2 | $19K | Hold |
343
| – | – | 0.02% | 204 |
|
|
2018
Q1 | $22K | Hold |
343
| – | – | 0.02% | 170 |
|
|
2017
Q4 | $21K | Hold |
343
| – | – | 0.02% | 157 |
|
|
2017
Q3 | $22K | Hold |
343
| – | – | 0.02% | 152 |
|
|
2017
Q2 | $19K | Hold |
343
| – | – | 0.02% | 155 |
|
|
2017
Q1 | $19K | Hold |
343
| – | – | 0.02% | 160 |
|
|
2016
Q4 | $20K | Hold |
343
| – | – | 0.02% | 154 |
|
|
2016
Q3 | $25K | Hold |
343
| – | – | 0.03% | 159 |
|
|
2016
Q2 | $25K | Hold |
343
| – | – | 0.03% | 159 |
|
|
2016
Q1 | $22K | Hold |
343
| – | – | 0.02% | 165 |
|
|
2015
Q4 | $24K | Hold |
343
| – | – | 0.02% | 167 |
|
|
2015
Q3 | $20K | Buy |
343
+203
| +145% | +$12.9K | 0.02% | 179 |
|
|
2015
Q2 | $9K | Sell |
140
-200
| -59% | -$13.2K | 0.01% | 228 |
|
|
2015
Q1 | $22K | Hold |
340
| – | – | 0.02% | 199 |
|
|
2014
Q4 | $20K | Hold |
340
| – | – | 0.02% | 205 |
|
|
2014
Q3 | $17K | Hold |
340
| – | – | 0.01% | 224 |
|
|
2014
Q2 | $16K | Hold |
340
| – | – | 0.01% | 222 |
|
|
2014
Q1 | $18K | Hold |
340
| – | – | 0.01% | 214 |
|
|
2013
Q4 | $18K | Buy |
+340
| New | +$17.3K | 0.01% | 208 |
|
Other funds holding BMY
Cordasco Financial Network's BMY Position: Q2 2022 in Review
Cordasco Financial Network increased its Bristol-Myers Squibb (BMY) stake by 0.61% in Q2 2022, buying an estimated $609 and bringing the position to 1,315 shares worth $101K. The position accounts for 0.07% of the portfolio, ranked #131.
Cordasco Financial Network first reported a position in BMY in Q4 2013 and has held it in 35 quarters since. 2,538 funds tracked by Wall St. Rank hold BMY as of Q2 2022.
- Cordasco Financial Network held 1,315 shares of Bristol-Myers Squibb worth $101K as of Q2 2022.
- Cordasco Financial Network bought 8 Bristol-Myers Squibb shares in Q2 2022, an estimated $609.
- Bristol-Myers Squibb made up 0.07% of Cordasco Financial Network's portfolio in Q2 2022, its #131 holding.
- Cordasco Financial Network first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 35 quarters since.
- 2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.
Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.